Japan - Scientists have once again commended the benefits of fish-oil supplements in promoting cardiovascular health. The recent study exclaims the benefits of using fish oil supplements containing omega-3 fatty acid or eicosapentaenoic acid with statin therapy, in reducing the risk of major coronary events.
During a study involving more than 18,000 patients suffering hypercholesterolemia and family history of coronary artery disease, it was observed that combining eicosapentaenoic acid with statins brought about a decline in the rate of major coronary events by 19%. The use of statin alone did not prove as good.
Eicosapentaenoic acid, (EPA) was beneficial to patients suffering unstable angina and non-fatal coronary events, but researchers found no significant difference in the rates of sudden cardiac death or coronary death.
The authors concluded, "The frequency of fatal or non-fatal myocardial infarction was not significantly reduced (23%) in the EPA group. However, that of non-fatal coronary events (including non-fatal myocardial infarction, unstable angina, and events of angioplasty, stenting, or coronary artery bypass grafting) was significantly lower (19%) in the EPA group than in controls."